Sartorius Stedim Biotech Investor Relations Service

Conference Call on 1st Quarter 2014 Figures

Joachim Kreuzburg, CEO and Chairman of the Board of the Sartorius Stedim Biotech Group, will discuss the first quarter 2014 figures with analysts and investors on April 28, at 3.30 p.m. CET.

You may dial into the teleconference starting at 3.20 p.m. CET at the following numbers:

Germany: +49 (0)69 2222 10636
France: +33 (0)1 76 77 22 35
UK: +44 (0)20 3427 1928
USA: +1 646 254 3370

The dial-in code is: 2162619.

Reference Document 2013

Download pdf (3.6 MB)

News

Proposals by the Board of Directors to the AGM

Dividend to increase by 9.1% | Share capital measures[more]

Date: 21.02.2014     Category: Sartorius Stedim Biotech

Preliminary Results 2013

New Highs in Revenues and Earnings – Financial Targets Fully Achieved – Strong 2014 Outlook [more]

Date: 28.01.2014     Category: Sartorius Stedim Biotech

Sartorius Stedim Biotech Share (DIM)

Petra Kirchhoff

Vice President of Corporate Communications & Investor Relations

petra.kirchhoff
@sartorius.com

Phone: +49 551 308-1686

Andreas Theisen

Director Investor Relations

andreas.theisen
@sartorius.com

Phone: +49 551 308-1668